The Global Medically Prescribed Apps Market is segmented into the Americas, Europe, Asia
Pacific, and the Middle East and Africa on the basis of region.
The Americas, dominated by North America, is likely to emerge as the leading regional
segment of the global medically prescribed apps market over the forecast period. The region
held a dominant share of 47% in the global medically prescribed apps market in 2016 and is
likely to witness a steady rise in its share in the market over the forecast period due to the
growing prevalence of chronic conditions that require long-term monitoring, and the
increasing acceptance of medically prescribed apps from physicians and patients alike. The
unhealthy dietary and lifestyle choices of consumers in the region are likely to lead to
further growth in the prevalence of diseases such as diabetes and cardiovascular conditions,
lending further impetus to the medically prescribed apps market in the region.
Asia Pacific could exhibit robust growth in the medically prescribed apps market over the
forecast period due to the growing smartphone usage as well as the growing prevalence of
diabetes and cancer.